Obesity Drug Maker Metsera Seeks $100 Million IPO (IPO: NYSEARCA)


First public offering hologram, night panoramic view of Bangkok. A financial center for multinational corporations in Asia. The concept of stimulating growth through the IPO process. Double exposure.

2d illustrations and photos

Metsera ( MTSR ), which develops ultra-long-acting drugs to treat obesity, has filed for a $100 million initial public offering.

While the company did not specify the conditions in its SEC filinghe indicated in the filing fee schedule that he did



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *